Identification of β-Secretase (BACE1) Substrates Using Quantitative ProteomicsMatthew L. Hemming, Dennis J. Selkoe|PLoS ONE|2009Cited by 192
Gastrointestinal stromal tumor enhancers support a transcription factor network predictive of clinical outcomeMatthew L. Hemming, James E. Bradner, Matthew A. Lawlor et al.|Proceedings of the National Academy of Sciences|2018Cited by 43
Response and Mechanisms of Resistance to Larotrectinib and Selitrectinib in Metastatic Undifferentiated Sarcoma Harboring Oncogenic Fusion of <i>NTRK1</i>Matthew L. Hemming, Sandro Santagata, Michael J. Nathenson et al.|JCO Precision Oncology|2020Cited by 36
HAND1 and BARX1 Act as Transcriptional and Anatomic Determinants of Malignancy in Gastrointestinal Stromal TumorMatthew L. Hemming, Sandro Santagata, George D. Demetri et al.|Clinical Cancer Research|2021Cited by 29
ASPSCR1::TFE3 Drives Alveolar Soft Part Sarcoma by Inducing Targetable Transcriptional ProgramsEwa Sicinska, Matthew L. Hemming|Cancer Research|2024Cited by 10